LRMR
Larimar Therapeutics Inc.
$3.56
+$0.19(+5.64%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$292.72M
Volume
1.15M
52W Range
$1.61 - $6.91
Target Price
$16.70
Key Metrics Overview
| Market Cap | $292.72M | P/E Ratio | N/A |
| 52W High | $6.91 | 52W Low | $1.61 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 23.5% | 52W Position | 36.8% |
| Overall Score | 39 | Value Score | 60 |
| Quality Score | -- | Technical Score | 18 |
Growth Analysis
| EPS Current Est | $-1.89 | EPS Next Est | $-1.75 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $3.56 | +5.6% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW